UNSPSC 85516217: Insertion of intraluminal device into left femoral artery, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of intraluminal device into left femoral artery, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04HL4DZ

UNSPSC 85516217 Insertion of intraluminal device into left femoral artery, percutaneous endoscopic approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific surgical procedure involving vascular intervention, yet the recent opportunities tagged to this code encompass occupational medical surveillance, disability medical evaluation services, pharmacy benefit management, temporary health professional staffing, surgical benefit carve-out programs, and emergency medical services for detained youth — none of which involve intraluminal device placement or percutaneous vascular procedures. The mismatch suggests either a tagging error in the underlying procurement database or that this Commodity code is not in active use for state and local contracting at present.

Recent solicitations bearing this code come from the Washington State Department of Transportation (occupational health examinations across ferry system locations, RFP due October 9, 2026), the City of Phoenix Retirement Office (disability medical record review and independent medical evaluations for pension applicants, RFP due October 16, 2026), the City of Long Beach (surgical benefit carve-out program for Centers of Excellence, RFP due October 7, 2026), Harris County Juvenile Probation Department (emergency and specialty medical services for detained youth, RFI due September 25, 2026), Santa Clara County Health System (temporary ancillary clinical staffing qualification pool, proposals due October 7, 2026), and Collier County (pharmacy benefit management, RFP due April 9, 2026). The geographic spread reflects activity in Washington, Arizona, California, and Florida. No evidence supports active state or local procurement specifically for the vascular intervention device or procedure named in the Commodity code itself.